Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience
Molecular Therapy · 2025-04 · 33 (4) · 1449-1465
DOI: 10.1016/j.ymthe.2025.02.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2025-04. Verfasst von Joan Roig-Soriano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Institut de Neurociènces (INc), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona…. Hauptthemen laut MEDLINE: Longevity, Glucuronidase. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Departament d'Universitats, Recerca i Societat de la Informació, Spain Ministry of Science and Innovation.
Abstract (Originalsprache)
Aging is a major risk factor for pathologies including sarcopenia, osteoporosis, and cognitive decline, which bring suffering, disability, and elevated economic and social costs. Therefore, new therapies are needed to achieve healthy aging. The protein Klotho (KL) has emerged as a promising anti-aging molecule due to its pleiotropic actions modulating insulin, insulin-like growth factor-1, and Wnt signaling pathways and reducing inflammatory and oxidative stress. Here, we explored the anti-aging potential of the secreted isoform of this protein on the non-pathological aging progression of wild-type mice. The delivery of an adeno-associated virus serotype 9 (AAV9) coding for secreted KL (s-KL) efficiently increased the concentration of s-KL in serum, resulting in a 20% increase in lifespan. Notably, KL treatment improved physical fitness, related to a reduction in muscle fibrosis and an increase in muscular regenerative capacity. KL treatment also improved bone microstructural parameters associated with osteoporosis. Finally, s-KL-treated mice exhibited increased cellular markers of adult neurogenesis and immune response, with transcriptomic analysis revealing induced phagocytosis and immune cell activity in the aged hippocampus. These results show the potential of elevating s-KL expression to simultaneously reduce the age-associated degeneration in multiple organs, increasing both life and health span.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut de Neurociènces (INc), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
- Institut de Neurociènces (INc), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain.
- Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain.
- Department of Medicine and Life Sciences, Pompeu Fabra University, 08003 Barcelona, Spain; Altos Labs, San Diego Institute of Science, San Diego, CA 92122, USA.
- ADvantage Therapeutics, Inc., Miami, FL 33127, USA.
- Institut de Neurociènces (INc), Universitat Autònoma de Barcelona, 08193 Bellaterra, Spain; Vall d'Hebron Institut de Recerca (VHIR), 08035 Barcelona, Spain; Ciberned, Instituto de Salud Carlos III, 28029 Madrid, Spain.
Förderung
- NICHD NIH HHS
- Departament d'Universitats, Recerca i Societat de la Informació
- Spain Ministry of Science and Innovation
- Generalitat de Catalunya
- Ministerio de Ciencia e Innovación
- Carlos III Health Institute
Zitieren
APA
Roig-Soriano, J., Edo, Á., Verdés, S., Martín-Alonso, C., Sánchez-de-Diego, C., Rodriguez-Estevez, L., Serrano, A. L., Abraham, C. R., Bosch, A., Ventura, F., Jordan, B. A., Muñoz-Cánoves, P., & Chillón, M. (2025). Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience. Molecular Therapy, 33(4), 1449-1465. https://doi.org/10.1016/j.ymthe.2025.02.030
Vancouver
Roig-Soriano J, Edo Á, Verdés S, Martín-Alonso C, Sánchez-de-Diego C, Rodriguez-Estevez L, et al. Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience. Molecular Therapy. 2025;33(4):1449-1465. doi:10.1016/j.ymthe.2025.02.030
BibTeX
@article{RoigSoriano2025,
author = {Roig-Soriano, Joan and Edo, Ángel and Verdés, Sergi and Martín-Alonso, Carlos and Sánchez-de-Diego, Cristina and Rodriguez-Estevez, Laura and Serrano, Antonio L and Abraham, Carmela R and Bosch, Assumpció and Ventura, Francesc and Jordan, Bryen A and Muñoz-Cánoves, Pura and Chillón, Miguel},
title = {Long-term effects of s-KL treatment in wild-type mice: Enhancing longevity, physical well-being, and neurological resilience},
journal = {Molecular Therapy},
year = {2025},
volume = {33},
number = {4},
pages = {1449--1465},
doi = {10.1016/j.ymthe.2025.02.030}
}
EUVIMED